Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPrimorus Inv. Regulatory News (PRIM)

Share Price Information for Primorus Inv. (PRIM)

Share Price is delayed by 15 minutes
Get Live Data
3.70    0.00 (0.00%)
Bid:
3.40
Ask:
4.00
Spread: 0.60 (17.647%)
Market Cap: £4.61m
PRIM Live PriceLast checked at - London Stock Exchange

Intraday Primorus Inv. Share Chart

Loan Note Investment - Zuuse Pty Ltd

16 Oct 2018 07:00

RNS Number : 1230E
Primorus Investments PLC
16 October 2018
 

Primorus Investments plc

("Primorus" or the "Company")

 Loan Note Investment - Zuuse Pty Ltd

 

Primorus Investments plc (AIM: PRIM, NEX: PRIM) is pleased to report that it has invested A$500,000 (circa £272,000) in a fully subscribed A$5m Series B Loan Note to an Australian-based, international construction software and payments company Zuuse Pty Ltd ("Zuuse"). The Series B Loan Note has a 12-month term, yielding an attractive coupon of 12% and the added attraction of free attaching options over approximately 0.8% of Zuuse which expire on 30 September 2021.

 

Zuuse is based in Australia with offices in the UK and the US and has two core platforms, Zuuse Construction and Zuuse Building Operations. Through its sub-brand Zuuse Lifecycle, it services a significant number of assets across Australia and the UK including hospitals, universities, hotels, office blocks, bridges and sports stadiums. Through its Payapps and GC Pay Brands, Zuuse services small, medium and large construction companies as well as thousands of subcontractor groups and facilitates over A$12B in annualised payment values across its platforms.

 

With forecast global revenues growing at circa 60% per annum, Zuuse has, in 2019, forecast revenues of A$16A$18m and a positive EBITDA of A$3m to A$5m.

 

Alastair Clayton, Executive Director of Primorus, is a circa 2.75% shareholder of Zuuse and therefore did not participate in the board decision to approve this investment.

 

Further information on can be found at:

www.zuuse.com

www.payapps.com

www.gcpay.com

 

Jeremy Taylor-Firth, Non-Executive Chairman Commented;

 

"I am pleased that we have been able to participate in this fully subscribed A$5m Series B 12 month Loan Note. The rationale behind the investment was to manage short to medium term cash reserves in a more efficient manner and the 12% coupon for the risk-profile was highly attractive on its own right. That we also receive options over approximately 0.8% of Zuuse is a real bonus and gives us a longer-term stake in what is a rapidly growing global software business."

 

He added;

 

"As will be evidenced in our soon to be released Quarter 3 report to shareholders, Primorus has a debt-free balance sheet with cash reserves and liquid shares comprising a very large proportion of its current quoted market value. Our core value proposition is a multi-million pound portfolio of private and pre-IPO investments built over the last 18 months. The portfolio is beginning to mature to the point where we can see potential investment exits on the horizon and the Board believes that the best way to deliver tangible shareholder value is to demonstrate profitable exits to grow the share price and once we have built a larger balance sheet to support ongoing investing, return excess cash to shareholders."

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

For further information, please contact:

Primorus Investments plc:

+44 (0) 20 7440 0640

Alastair Clayton

Nominated Adviser:

+44 (0) 20 7213 0880

Cairn Financial Advisers LLP

James Caithie / Sandy Jamieson

Broker:

+44 (0) 20 3621 4120

Turner Pope Investments

Andy Thacker

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCDXBDGIGBBGIU
Date   Source Headline
2nd Jun 20269:35 amRNSFinal Results
24th Apr 20262:00 pmRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSFurther Investment in Fresho Pty Ltd
10th Feb 20267:00 amRNSBoard role changes
15th Jan 20264:38 pmRNSHolding(s) in Company
9th Jan 20267:00 amRNSTransaction in Own Shares & TR1
8th Jan 20267:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
18th Dec 20257:00 amRNSTransaction in Own Shares
29th Oct 20257:00 amRNSTransaction in Own Shares
20th Oct 20257:00 amRNSTransaction in Own Shares
9th Oct 20257:00 amRNSTransaction in Own Shares
2nd Oct 20257:00 amRNSTransaction in Own Shares
24th Sep 20257:00 amRNSInvestee Company Update - Virtualstock
23rd Sep 20257:00 amRNSHalf-year Report
20th Aug 20257:00 amRNSTransaction in Own Shares
6th Aug 20252:01 pmRNSHolding(s) in Company
6th Aug 20257:00 amRNSTransaction in Own Shares & TR-1
28th Jul 20257:00 amRNSTransaction in Own Shares
25th Jul 20257:00 amRNSHolding(s) in Company
24th Jul 20257:48 amRNSTransaction in Own Shares
18th Jul 20254:12 pmRNSHolding(s) in Company
17th Jul 20257:00 amRNSTransaction in Own Shares & TR-1
16th Jul 20257:00 amRNSTransaction in Own Shares
15th Jul 20257:00 amRNSTransaction in Own Shares
14th Jul 202512:30 pmRNSAnnouncement by Pri0r1ty Intelligence Group PLC
11th Jul 20258:03 amRNSTransaction in Own Shares
11th Jul 20257:00 amRNSHolding(s) in Company
10th Jul 20257:00 amRNSTransaction in Own Shares
9th Jul 20257:00 amRNSTransaction in Own Shares
8th Jul 20251:35 pmRNSResult of AGM
25th Jun 202510:05 amRNSHoldings in Company
25th Jun 20257:00 amRNSInvestee Company Update - Pri0r1ty
13th Jun 20257:00 amRNSNotice of AGM & Proposed Rule 9 Waiver
30th May 20254:25 pmRNSFinal Results
31st Mar 20257:00 amRNSFurther Investment in Interpac Ltd
20th Jan 202511:00 amRNSDirector/PDMR Shareholding
20th Jan 202511:00 amRNSHolding(s) in Company
23rd Dec 20242:10 pmRNSInvestee Company Update – Alteration Earth
5th Nov 20247:00 amRNSSale Of Engage Shareholding
23rd Oct 202412:10 pmRNSHolding(s) in Company
30th Sep 20247:00 amRNSHolding(s) in Company
27th Sep 20245:05 pmRNSDirector/PDMR Shareholding
20th Sep 20241:10 pmRNSFurther Investment - Replacement
20th Sep 20247:00 amRNSFurther Investment in Fresho Pty Ltd
5th Sep 20247:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.